Insulin glargine and lixisenatide Subcutaneous and Kalexate Powder
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Kalexate Powder and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Kalexate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Kalliga
- Insulin glargine and lixisenatide Subcutaneous-Kalosar
- Insulin glargine and lixisenatide Subcutaneous-Kalydeco
- Insulin glargine and lixisenatide Subcutaneous-Kalydeco (Ivacaftor Granules)
- Insulin glargine and lixisenatide Subcutaneous-Kalydeco (Ivacaftor Tablets)
- Insulin glargine and lixisenatide Subcutaneous-Kanamycin
- Kalexate Powder-Insulin glargine, recombinant Subcutaneous
- Kalexate Powder-Insulin glulisine
- Kalexate Powder-Insulin Glulisine (Cartridges and Pens)
- Kalexate Powder-Insulin Glulisine (Vials)
- Kalexate Powder-Insulin glulisine Subcutaneous
- Kalexate Powder-Insulin human inhaled Inhalation